Owner only: item control page
Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies
Thomalla, D., Beckmann, L.
, Grimm, C.
, Oliverio, M.
, Meder, L., Herling, C. D., Nieper, P., Feldmann, T., Merkel, O., Lorsy, E., da Palma Guerreiro, A., von Jan, J., Kisis, I.
, Wasserburger, E., Claasen, J., Faitschuk-Meyer, E., Altmüller, J., Nürnberg, P., Yang, T.-P., Lienhard, M., Herwig, R.
, Kreuzer, K.-A., Pallasch, C. P.
, Büttner, R., Schäfer, S. C., Hartley, J., Abken, H., Peifer, M., Kashkar, H., Knittel, G., Eichhorst, B., Ullrich, R. T., Herling, M., Reinhardt, H. C., Hallek, M.
, Schweiger, M. R.
and Frenzel, L. P.
(2022)
Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies.
Blood 140 (20), pp. 2113-2126.
Date of publication of this fulltext: 29 Feb 2024 12:58
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Blood | ||||
| Publisher: | AMER SOC HEMATOLOGY | ||||
|---|---|---|---|---|---|
| Place of Publication: | WASHINGTON | ||||
| Volume: | 140 | ||||
| Number of Issue or Book Chapter: | 20 | ||||
| Page Range: | pp. 2113-2126 | ||||
| Date | 2022 | ||||
| Institutions | Leibniz Institute for Immunotherapy (LIT) | ||||
| Identification Number |
| ||||
| Keywords | PROGNOSTIC-SIGNIFICANCE; DNA METHYLATION; CELL-DEATH; EXPRESSION; BCL-2; APOPTOSIS; PUMA; BAX; LEUKEMIA; CANCER; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 57589 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric